Beta Drugs Limited - Company Profile

It is a pharma public limited company based in Baddi, Himachal Pradesh, India, established in 2005.
2005 Baddi, Himachal Pradesh, India Active
Last Updated:
Access Report
About Beta Drugs Limited

Beta Drugs Limited, a active public limited company, was established on 21 September 2005 in Baddi, Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24230HP2005PLC028969. Registered under ROC Roc Himachal Pradesh. it is listed on NSE: BETA. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹10.14 Cr.

Formerly known as Beta Drugs Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹199.35 Cr and a net worth of ₹116.01 Cr. Employing 382 professional, Its leadership includes Rohit Parti (Director), Rahul Batra (Managing Director), Ajay Mahipal (Director). Past directors included Rohit Parti, Rahul Batra, Neeraj Batra. It holds ₹46.61 Cr open charges and ₹23.14 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Village Nandpur, Baddi, Himachal Pradesh, 174101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24230HP2005PLC028969

  • Registration Number

    028969

  • Incorporation Date

    21 September 2005

  • Authorized Capital

    ₹11.00 Cr

  • Paid-Up Capital

    ₹10.14 Cr

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Listed (NSE: BETA)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 11.00 Cr
  • Paid Up Capital ₹ 10.14 Cr
  • Company Age 20 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 46.61 Cr
  • Satisfied Charges ₹ 23.14 Cr
  • Revenue Growth **** 25.44%
  • Profit Growth **** 16.58%
  • Ebitda **** 7.77%
  • Net Worth 20.52%
  • Total Assets **** 27.17%
Company report

Beta Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Beta Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Beta Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Rohit Parti Director 26 Jul 2017 Current
Rahul Batra Managing Director 01 Aug 2014 Current
Ajay Mahipal Director 27 Nov 2024 Current
Sanjay Sehgal Director 27 Nov 2024 Current
Varun Batra Managing Director 01 Aug 2014 Current
Nipun Arora Cfo 05 Mar 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 28 Sep 2018 Past
Pramod Abcsdd Whole-Time Director 27 Jan 2021 Past
Pramod Abcsdd Whole-Time Director 05 Dec 2018 Past
Pramod Abcsdd Additional Director 20 Dec 2024 Past
Pramod Abcsdd Cfo 04 Mar 2021 Past
Pramod Abcsdd Additional Director 20 Dec 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Beta Drugs.

Beta Drugs Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 25.44% increase. The company also saw a substantial improvement in profitability, with a 16.58% increase in profit. The company's net worth Soared by an impressive increase of 20.52%.

Beta Drugs revenue growth over time
Beta Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 25.44%
*******
*******
*******
*******
Revenue from Operations
*******
 25.18%
*******
*******
*******
*******
Total Assets
*******
 27.17%
*******
*******
*******
*******
Profit or Loss
*******
 16.58%
*******
*******
*******
*******
Net Worth
*******
 20.52%
*******
*******
*******
*******
EBITDA
*******
 7.77%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Beta Drugs?

In 2024, Beta Drugs had a promoter holding of 66.73% and a public holding of 33.25%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹466,107,925.00

Satisfied Charges

₹231,393,145.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 16.90 Cr
  • Sidbi : 10.42 Cr
  • Others : 9.11 Cr
  • Uco Bank : 7.50 Cr
  • Axis Bank Limited : 2.68 Cr
Latest Charge Details
Date Lender Amount Status
08 Sep 2025 Sidbi ₹1.42 Cr Open
02 Jul 2025 Sidbi ₹1.50 Cr Open
15 May 2025 Others ₹7.00 Cr Open
29 Mar 2025 Axis Bank Limited ₹1.98 Cr Open
27 Mar 2025 Sidbi ₹3.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Beta Drugs?

Beta Drugs has a workforce of 382 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Beta Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beta Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Beta Drugs
Recent Activity within the Organization
  • Charges

    A charge registered on 29 Jul 2024 via Charge ID 100955576 with Hdfc Bank Limited was fully satisfied on 03 Dec 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 16.50 Cr registered on 08 Oct 2020 with Charge ID 100379428 was modified on 03 Nov 2025. was documented.

  • Annual General Meeting

    Progress on Beta Drugs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Sidbi amounted to Rs. 1.42 Cr with Charge ID 101152706 was registered on 08 Sep 2025. was completed.

  • Charges

    A charge with Sidbi amounted to Rs. 1.50 Cr with Charge ID 101125694 was registered on 02 Jul 2025. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 7.00 Cr with Charge ID 101097354 was registered on 15 May 2025. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Beta Drugs Limited?

The CIN of Beta Drugs Limited is L24230HP2005PLC028969.

Where is Beta Drugs Limited headquartered?

Beta Drugs Limited is headquartered at Village Nandpur, Baddi, Himachal Pradesh, 174101.

When was Beta Drugs Limited incorporated?

Beta Drugs Limited was incorporated on 21 September 2005.

Who are the current directors of Beta Drugs Limited?

The current directors of Beta Drugs Limited are

What is the primary industry of Beta Drugs Limited?

The primary industry of Beta Drugs Limited is Manufacturing.

Is Beta Drugs Limited a listed company?

Beta Drugs Limited is listed. It is listed on NSE: BETA.

What is the capital structure of Beta Drugs Limited?

The authorized capital of Beta Drugs Limited is ₹11.00 Cr, and the paid-up capital is ₹10.14 Cr.

What is the compliance status of Beta Drugs Limited?

The compliance status of Beta Drugs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available